M&A Deal Summary |
|
---|---|
Date | 2022-09-26 |
Target | Fidelis Research |
Sector | Life Science |
Buyer(s) | BioIVT |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
BioIVT is a provider of biological products to life sciences and pharmaceutical companies. BioIVT specializes in control and disease state matrices manufactured from human and animal blood, plasma, serum, tissues, and other fluids which are used in drug discovery, compound development, clinical and research diagnostics. BioIVT was founded in 1981 and is based in Hicksville, New York.
DEAL STATS | # |
---|---|
Overall | 15 of 17 |
Sector (Life Science) | 12 of 14 |
Type (Add-on Acquisition) | 14 of 16 |
Country (Bulgaria) | 1 of 1 |
Year (2022) | 4 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-09-12 |
XenoTech
Kansas, Kansas, United States XenoTech is a specialty global Contract Research Organization (CRO) specializing in ADME/DMPK/DDI testing of potential drug candidates. XenoTech is a provider of products for ADME-Tox in vitro models and contract research services. XenoTech is based in Kansas City. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2023-07-18 |
PrecisionMed
Carlsbad, California, United States PrecisionMed is a provider of high-quality human biological material for genetics, drug discovery, and biomarker research and in vitro diagnostics. PrecisionMed was founded in 1996 and is based in Carlsbad, California. |
Buy | - |